Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The IsraelIRLCF -13.45%65 Debt-to-EBITDA is 2.22 as of Mar. 2026, which is 10% below its 10-year median of 2.48. GuruFocus rates IRLCF with a GF Score™ of 65/100 and a GF Value™ of $273.43. The stock has 5 warning signs investors should review. Among 1,235 Chemicals companies, The Israel ranks worse than 57.73% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for The Israel's Debt-to-EBITDA or its related term are showing as below:
IRLCF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.97 Med: 2.48 Max: 12.1
Current: 2.75
During the past 13 years, the highest Debt-to-EBITDA Ratio of The Israel was 12.10. The lowest was 0.97. And the median was 2.48.
IRLCF's Debt-to-EBITDA is ranked worse than 57.73% of 1235
companies
in the Chemicals industry
Industry Median: 2.16
vs IRLCF: 2.75
The Israel (OTCPK:IRLCF) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The Israel Debt-to-EBITDA Related Terms
The Israel Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for The Israel's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, The Israel's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Israel Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, The Israel's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where The Israel's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
The Israel (IRLCF) has a Debt-to-EBITDA of 2.22 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on The Israel. This is 10% below median its historical median of 2.48. Over the past decade, The Israel's Debt-to-EBITDA has ranged from 0.97 to 12.10. According to the industry distribution chart, The Israel ranks #713 out of 1235 companies in the Chemicals industry, placing it in the top 57.7%.
Is The Israel's Debt-to-EBITDA too high?
The Israel's current Debt-to-EBITDA of 2.22 is 10% below median its 10-year median of 2.48. Over the past 10 years, this metric has ranged from a low of 0.97 to a high of 12.10. The Chemicals industry median Debt-to-EBITDA is 2.16. The Israel's value of 2.22 is 2.8% above this industry median. Based on the distribution chart, The Israel ranks #713 out of 1235 companies in the Chemicals industry, which is below the industry midpoint. Overall, The Israel has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does The Israel's Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, The Israel ranks #713 out of 1235 companies for Debt-to-EBITDA. This places The Israel in the lower half of its industry. The industry median Debt-to-EBITDA is 2.16. The Israel's value of 2.22 is 2.8% above this benchmark. Historically, The Israel's own Debt-to-EBITDA has ranged from 0.97 to 12.10 over the past decade. While the company's 10-year median is 2.48 vs. the industry median of 2.16, The Israel has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,235 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Israel's current Debt-to-EBITDA of 2.22 is 2.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on The Israel. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Israel's current Debt-to-EBITDA is 2.22, which is 10% below median its own 10-year median of 2.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
The Israel (IRLCF) has a current Debt-to-EBITDA of 2.22. The stock's GF Value™ is $273.43, compared to a current price of $238.00 — trading 13% below its estimated fair value. The current Debt-to-EBITDA is 2.22, which is 10% below median its 10-year median of 2.48 and 2.8% above the Chemicals industry median of 2.16. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For The Israel (IRLCF), the current Debt-to-EBITDA is 2.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Israel (IRLCF) Overvalued in 2026?
Based on GuruFocus' analysis, The Israel stock appears to be undervalued.
The current stock price of $238.00 is trading 13% below its estimated GF Value™ of $273.43.
Key valuation signals for IRLCF:
Debt-to-EBITDA: 2.22 (10% below median its 10-year median of 2.48)
GF Value™: $273.43 vs. price of $238.00 (13% below fair value)
Industry Position: 2.8% above the Chemicals median (#713 of 1235)
No single metric tells the full story. See the IRLCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score
Get the complete analysis for IRLCF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRLCF has been successfully added to your 
